Roswell Park Cancer Institute
2 clinical trials · 2 recruiting · OTHER
Trials by Roswell Park Cancer Institute
RECRUITINGPhase 1NCT06622005
SX-682 in Combination With Carfilzomib, Daratumumab-Hyaluronidase, and Dexamethasone in Patients With Relapsed or...
This phase I trial tests the safety and side effects of SX-682 in combination with standard of care treatment carfilzomib, daratumumab-hyaluronidase, and dexamethasone in treating...
Sponsor: Roswell Park Cancer InstituteEnrolling: 151 location
Recurrent Multiple MyelomaRefractory Multiple Myeloma
RECRUITINGPhase 1NCT06305598
Bipolar Androgen Therapy to Restore Sensitivity to Androgen Deprivation Therapy for Patients With Metastatic Castration...
This phase I trial tests the change in androgen receptor sensitivity, side effects and effectiveness of bipolar androgen therapy, using testosterone, in patients with castration...
Sponsor: Roswell Park Cancer InstituteEnrolling: 141 location
Castration-Resistant Prostate CarcinomaMetastatic Prostate CarcinomaStage IVB Prostate Cancer AJCC v8